Breaking News Instant updates and real-time market news.

DVN

Devon Energy

$42.41

0.35 (0.83%)

, VMW

VMware

$152.24

0.26 (0.17%)

17:06
08/14/18
08/14
17:06
08/14/18
17:06

Elliott adds Devon, VMware, exits Energen

Paul Singer's Elliott Management disclosed in an SEC filing its holdings as of June 30, 2018. The fund's four new buys in the quarter were, in order of size, Devon Energy (DVN), VMware (VMW), 21st Century Fox (FOX), and Sempra Energy (SRE). Elliott exited five positions during the quarter, including by size of previous position Energen (EGN), Teradyne (TER), Nomad Foods (NOMD), and VICI Properties (VICI). The fund increased its stake in 11 holdings, including by size of previous position Hess (HES), Dish (DISH), EQT Corp. (EQT), Micro Focus International (MFGP), and Invesco QQQ Trust Series 1 (QQQ). Elliott decreased its stake in four holdings, including by size CDK Global (CDK), Investors Bancorp (ISBC), Wipro (WIT), and Imperva (IMPV). The fund's told holdings as of June 30, in order of size, were NXP Semiconductors (NXPI), Peabody Energy (BTU), Hess, Arconic (ARNC), and CDK Global.

DVN

Devon Energy

$42.41

0.35 (0.83%)

VMW

VMware

$152.24

0.26 (0.17%)

FOX

21st Century Fox

$44.97

0.25 (0.56%)

FOXA

21st Century Fox

$45.48

0.17 (0.38%)

SRE

Sempra Energy

$114.22

-0.67 (-0.58%)

EGN

Energen

$73.15

1.76 (2.47%)

TER

Teradyne

$41.86

0.24 (0.58%)

NOMD

Nomad Foods

$19.54

0.04 (0.21%)

VICI

VICI Properties

$20.12

0.04 (0.20%)

HES

Hess Corp.

$63.92

0.6 (0.95%)

DISH

Dish

$35.63

0.63 (1.80%)

EQT

EQT Corporation

$50.34

0.98 (1.99%)

MFGP

Micro Focus

$15.79

-0.325 (-2.02%)

QQQ

Invesco QQQ Trust

$181.44

1.1 (0.61%)

CDK

CDK Global

$61.75

-2.08 (-3.26%)

ISBC

Investors Bancorp

$12.77

0.17 (1.35%)

WIT

Wipro

$5.12

(0.00%)

IMPV

Imperva

$45.55

-0.85 (-1.83%)

NXPI

NXP Semiconductors

$91.21

-1.92 (-2.06%)

BTU

Peabody Energy

$42.39

-0.12 (-0.28%)

ARNC

Arconic

$20.69

0.29 (1.42%)

  • 14

    Aug

  • 14

    Aug

  • 23

    Aug

  • 10

    Sep

  • 11

    Sep

  • 12

    Sep

  • 29

    Oct

  • 06

    Nov

DVN Devon Energy
$42.41

0.35 (0.83%)

07/24/18
MZHO
07/24/18
INITIATION
Target $173
MZHO
Buy
Mizuho names 'Apple of oil' EOG top pick in Oil & Gas sector
Mizuho analyst Paul Sankey last night initiated 10 names in the Global Oil & Gas group with five buys, four neutrals and one underperform. He also maintained a Buy rating on Occidental Petroleum (OXY) and Neutral rating on ConocoPhillips (COP). The analyst put Buy ratings on EOG Resources (EOG), his top pick in the group, Anadarko Petroleum (APC), Pioneer Natural Resources (PXD), Noble Energy (NBL) and Suncor (SU). Sankey calls EOG the Apple (AAPL) of oil. The company has been a pioneer in unconventional oil development in the U.S. and its technology-driven, innovation-focused approach will continue to drive peer-leading rates of return and oil growth, the analyst contends. He put Neutral ratings on Devon Energy (DVN), Hess Corp. (HES), Marathon Oil (MRO) and Apache (APA). Lastly, Sankey initiated Murphy Oil (MUR) with an Underperform rating and $36 price target. While the stock trades well below peers on both mid-cycle free cash and discount to net asset value, there is not enough potential upside to justify a Neutral at this point, Sankey told investors in a research note.
07/23/18
MZHO
07/23/18
INITIATION
Target $59
MZHO
Buy
Devon Energy initiated with a Buy at Mizuho
Mizuho analyst Paul Sankey started Devon Energy with a Buy rating and $59 price target.
08/06/18
UBSW
08/06/18
UPGRADE
Target $53
UBSW
Buy
Devon Energy upgraded to Buy from Neutral at UBS
UBS analyst Lloyd Byrne upgraded Devon Energy (DVN) to Buy and raised his price target for the shares to $53 from $45. Devon continues to take positive steps by focusing its inventory on its highest return assets, divesting EnLink (ENLK, ENLC) at a better than expected price, and having a material repurchase plan, Byrne tells investors in a research note. The analyst finds the stock's risk/reward as "compelling" at current levels. He sees 23% potential upside in the shares.
07/12/18
MSCO
07/12/18
INITIATION
Target $46
MSCO
Equal Weight
Devon Energy initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analysts Devin McDermott and Drew Venker added coverage of 12 large-cap and diversified E&Ps, including Devon Energy, which they started with a $46 price target and Equal Weight rating.
VMW VMware
$152.24

0.26 (0.17%)

08/13/18
OPCO
08/13/18
NO CHANGE
Target $170
OPCO
Outperform
VMware price target raised to $170 from $165 at Oppenheimer
Oppenheimer analyst Ittai Kidron raised his price target for VMware to $170 from $165, while reiterating an Outperform rating on the shares. Based on his U.S./European channel checks, the analyst sees upside potential to VMware's July-quarter consensus numbers, and expects in-line October-quarter guidance.
08/13/18
PIPR
08/13/18
NO CHANGE
Target $31
PIPR
Overweight
VMware now formidable long-term competitor to NetScout, says Piper Jaffray
Piper Jaffray analyst James Fish says VMware (VMW) is now a more formidable, long-term competitor to NetScout (NTCT) after it announced the acquisition of Dell-EMC's Service Assurance Suite. The analyst, however, believes the acquisition could create near-term opportunities for NetScout to gain market share. He reiterates an Overweight rating on NetScout shares with a $31 price target.
07/10/18
WELS
07/10/18
NO CHANGE
Target $155
WELS
Market Perform
VMware price target raised to $155 from $135 at Wells Fargo
Wells Fargo analyst Phil Winslow raised his price target for VMware (VMW) to $155 from $135 to account for the one-time special dividend and guidance announced in conjunction with Dell Technologies' acquisition of Class V common stock (DVMT) on July 2, 2018. The analyst reiterates a Market Perform rating on VMware's shares.
07/16/18
BOFA
07/16/18
NO CHANGE
Target $190
BOFA
Buy
VMware price target raised to $190 from $161 at BofA/Merrill
BofA/Merrill analyst Kash Rangan raised his price target on VMware (VMW) to $190 and kept his Buy rating, citing his "increased confidence in sustained mid-teens billings growth" as well as its better operating margins of 32% relative to 24% at competitor Red Hat (RHT). Rangan says that the reverse merger at Dell removes the overhang on VMware shares and should increase its valuation multiple in the long term. The analyst also states that his new valuation on the company implies a multiple of 19-times enterprise value to expected FY19 free cash flow, which is still a 15% discount to Red Hat's 22-times because of its slightly lower billings growth, but adds that VMware is still cheaper than Citrix (CTXS) in spite of its faster revenue growth.
FOX 21st Century Fox
$44.97

0.25 (0.56%)

07/13/18
07/13/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. VF CORP DOUBLE UPGRADE: BofA Merrill Lynch analyst Robert Ohmes upgraded VF Corp (VFC) to Buy from Underperform and raised his price objective to $96 from $65 ahead of the company's earnings report on July 20, telling investors in a research note that he believes Vans will be a "go-to-brand" for the back-to-school selling season. He said his channel checks indicate accelerating momentum in Vans, especially classic styles, and that the $50-$60 price point is attractive given consumers' shift to value. RAYMOND JAMES DOWNGRADES AT&T: Raymond James downgraded AT&T (T) to Market Perform from Outperform. Analyst Frank Louthan said he views the Department of Justice appeal of the Time Warner case as a negative and said it is a "frustrating delay." Louthan expects the suit to be a "significant overhang" for an extended period of time, which will limit share appreciation, but remains confident AT&T will prevail. AT&T is lower by 2% in late morning trading. STIFEL STARTS GALMED WITH A BUY: Stifel analyst Adam Walsh initiated Galmed (GLMD) with a Buy rating and $35 price target, calling it a "legitimate late-stage NASH play" after Aramchol recently proved itself in a Phase 2 trial as a clearly active and "very safe" compound for treating NASH. Galmed is trading higher by over 17% in late morning trading. MORGAN STANLEY HIKES WWE TARGET TO $100: Morgan Stanley analyst Benjamin Swinburne said that WWE (WWE), by securing rights fees in its new five-year agreements with NBC (CMCSA, CMCSK) and Fox (FOX, FOXA) that are 3.6 times higher than its prior five-year broadcast agreement with NBC, has gained a "massive increase" in earnings power and "extremely high" visibility into the associated revenue. Given the recently announced deals, he raised his price target on WWE shares to $100 from $58 and kept an Overweight rating on the stock. WILLIAM BLAIR CALLS KEMPER PULLBACK 'BUYING OPPORTUNITY': William Blair analyst Adam Klauber said he views shares of Kemper (KMPR) as "even more attractive" after the recent pullback, which he attributes to selling pressures from Infinity Property shareholders receiving Kemper stock. Klauber said Kemper "continues to be our top conviction idea," and kept an Outpeform rating on the name. Kemper is higher by 4.8% in late morning trading.
07/13/18
BERN
07/13/18
NO CHANGE
BERN
Bernstein 'not so sure' Comcast will give up on Fox assets
Bernstein analyst Todd Juenger said that it appears that the market is starting to believe Comcast (CMCSA) will give up on its bid to buy assets from 21st Century Fox (FOXA) and focus on Sky (SKYAY), but he said he is "not so sure" that is the case after only one counter from Disney (DIS). He does not believe Comcast would put forth a $35 bid unless it was prepared to bid up to near $45 per share, Juenger tells investors. If Comcast ups its bid, it either wins Fox at a high price or Disney is forced to pay more, which both seem better than giving up to him, Juenger stated. In any case, the "winner" will be left with increased leverage on a cyclical business late in the cycle at a time when it needs to invest significantly to build its direct-to-consumer business, added Juenger.
08/09/18
08/09/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Seagate (STX) downgraded to Sell from Neutral at Goldman Sachs by analyst Mark Delaney, who said that while Seagate has improved its product offerings in the last few years, hard disk drives remain a cyclical industry, and one "facing secular challenges in many parts of the market." 2. 21st Century Fox (FOXA) downgraded to Sector Perform from Outperform at RBC Capital by analyst Steven Cahall who noted that the stock is now trading near its M&A price and that he does not see any competitive bids emerging. 3. e.l.f. Beauty (ELF) downgraded to Hold from Buy at Jefferies by analyst Stephanie Wissink, who said she is disappointed with the company's "sales fall off," which she says "seems more systemic than previously assumed." e.l.f.'s profit advancement will reverse in the second half of the year amid stepped up brand investment. Shares were also downgraded to Underweight from Neutral at Piper Jaffray, who said she sees a "growing risk of shelf-space cuts into 2019" if underlying sales trends do not improve, at Citi to Neutral from Buy and at DA Davidson to Neutral from Buy. 4. Southern Company (SO) downgraded to Underperform from In Line at Evercore ISI by analyst Greg Gordon, who said he believes the shares are still not discounting enough risk after the company announced a $790M after-tax charge related to an increase in the cost estimate for constructing Vogtle Nuclear Plants 3 and 4. Shares were also downgraded to Underperform from Neutral at Credit Suisse, to Equal Weight from Overweight at Barclays and to Neutral from Buy at Guggenheim. 5. Schneider National (SNDR) downgraded to Underperform from Buy at BofA/Merrill by analyst Ken Hoexter, who cited "stretched" relative valuation. The analyst also downgraded Genesee & Wyoming (GWR) to Neutral from Buy, saying recent strength in shares has led to a premium multiple and sees minimal upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/09/18
08/09/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GOLDMAN CUTS SEAGATE TO SELL: Goldman Sachs analyst Mark Delaney downgraded Seagate Technology (STX) to Sell from Neutral and lowered his price target for the shares to $44 from $50, representing 20% downside from current levels. While Seagate has improved its product offerings in the last few years, hard disk drives remain a cyclical industry, and one "facing secular challenges in many parts of the market," Delaney said. He believes Seagate's fundamentals will peak in the second half of 2018 and decline in 2019. RBC CUTS FOX TO SECTOR PERFORM ON VALUATION: RBC Capital analyst Steven Cahall downgraded 21st Century Fox (FOXA) to Sector Perform from Outperform, but raised his price target to $49 from $45. The analyst noted that the stock is now trading near its M&A price and that he does not see any competitive bids emerging. Cahall adds that while the company is "undervalued", he awaits the separation to re-evaluate his stance. MORGAN STANLEY DOWNGRADES SEMI INDUSTRY: Morgan Stanley analyst Joseph Moore said he has become less constructive on semiconductor stocks through the year and he now believes elevated inventory levels and stretched lead times leave "no margin for error." Given his view that any lead time adjustment or demand slowdown could drive a "meaningful correction," Moore has downgraded his semiconductor industry view to Cautious from In-Line. He favors connector companies, like Amphenol (APH) and TE Connectivity (TEL) over analog/MCU at this point in the cycle, due to lower risk around lead time issues, Moore said. He also has a "strong preference" for high margin and more defensive models, such as Analog Devices (ADI) over lower margin and commodity exposed ones, like Cypress Semiconductor (CY) and ON Semiconductor (ON), he said. Despite his more cautious view on the space, Moore kept Overweight ratings on Nvidia (NVDA), Xilinx (XLNX) and Ambarella (AMBA), citing his view that they should benefit from secular growth in the area of AI, data center, and autonomous. SOUTHERN COMPANY GETS MULTIPLE DOWNGRADES AFTER Q2 REPORT: Barclays analyst Eric Beaumont downgraded Southern Company (SO) to Equal Weight and lowered his price target for the shares to $48 from $51. Credit Suisse analyst Michael Weinstein downgraded Southern Company to Underperform from Neutral and lowered his price target on the shares to $43 from $46. Guggenheim analyst Shahriar Pourreza downgraded Southern Company to Neutral from Buy and lowered his price target on the stock to $47 from $50. Evercore ISI analyst Greg Gordon downgraded Southern Company to Underperform from In Line and lowered his price target on Southern shares to $46 from $46.75.
FOXA 21st Century Fox
$45.48

0.17 (0.38%)

08/09/18
RBCM
08/09/18
DOWNGRADE
Target $49
RBCM
Sector Perform
21st Century Fox downgraded to Sector Perform at RBC Capital on valuation
As reported earlier, RBC Capital analyst Steven Cahall downgraded 21st Century Fox to Sector Perform from Outperform but raised his price target to $49 from $45. The analyst notes that the stock is now trading near its M&A price and that he does not see any competitive bids emerging. Cahall adds that while the company is "undervalued", he awaits the separation to re-evaluate his stance.
08/09/18
RBCM
08/09/18
DOWNGRADE
RBCM
Sector Perform
21st Century Fox downgraded to Sector Perform from Outperform at RBC Capital
SRE Sempra Energy
$114.22

-0.67 (-0.58%)

07/30/18
JPMS
07/30/18
NO CHANGE
Target $110
JPMS
Neutral
Sempra Energy LNG business worth $16 per share, says JPMorgan
JPMorgan analyst Christopher Turnure estimates "only" a $16 per share value for Sempra Energy's LNG business. In a research note titled "Checking the Math on LNG Enthusiasm; Business Worth $16/shr," the analyst keeps a Neutral rating on Sempra. He believes the company's "development upside optionality" is priced into the stock at current levels. Turnure raised his price target for the stock to $110 from $108.
08/10/18
08/10/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Stitch Fix (SFIX) initiated with a Buy at SunTrust. 2. Perspecta (PRSP) initiated with a Hold at Loop Capital. 3. EverQuote (EVER) initiated with a Buy at Needham. 4. Sempra Energy (SRE) resumed with an Equal Weight at Morgan Stanley. 5. Aramark (ARMK) initiated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/09/18
ARGS
07/09/18
NO CHANGE
Target $130
ARGS
Buy
Sempra Energy price target raised to $130 from $119 at Argus
Argus analyst Jacob Kilstein raised his price target on Sempra Energy to $130 and kept his Buy rating, citing the management's favorable guidance at its June 28th invest meeting. The analyst is also positive on the efforts made by activist investors Elliott Management and Bluescape Resources to increase profitability as they push for Sempra Energy to sells its international businesses and separate the company into a utility-focused entity and a natural gas infrastructure one. Kilstein further points to the management's estimates of the purchased Oncor majority stake to increase earnings by 10c-20c over the next four years.
08/10/18
MSCO
08/10/18
INITIATION
Target $120
MSCO
Equal Weight
Sempra Energy resumed with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Stephen C Byrd resumed coverage of Sempra Energy with an Equal Weight rating and $120 price target, as he currently sees too much uncertainty to fully include growth opportunities outside the company's base plan in his base case scenario. However, he notes that he sees the potential for significant additional upside from growth opportunities, such as Cameron LNG expansion, greater growth in California and South America, potential growth through the company's majority ownership stake in a leader in the Mexican energy sector, and the potential a buyer may value the LNG business at a lower cost of capital than he has applied.
EGN Energen
$73.15

1.76 (2.47%)

07/12/18
MSCO
07/12/18
DOWNGRADE
MSCO
Equal Weight
Energen downgraded to Equal Weight from Overweight at Morgan Stanley
08/08/18
IMPC
08/08/18
DOWNGRADE
Target $74
IMPC
In-Line
Energen downgraded to In-Line from Outperform at Imperial Capital
Imperial Capital analyst Irene Haas downgraded Energen to In-Line with an unchanged price target of $74. The analyst views the company's Q2 results as "strong" but finds the stock fairly valued at current levels.
07/12/18
07/12/18
DOWNGRADE
Target $76

Equal Weight
Energen downgraded to Equal Weight on valuation at Morgan Stanley
As previously reported, Morgan Stanley analyst Drew Venker downgraded Energen to Equal Weight from Overweight citing valuation after the stock's year-to-date outperformance compared to its Permian Basin peers. He lowered his price target on Energen shares to $76 from $93.
07/20/18
WILL
07/20/18
DOWNGRADE
WILL
Hold
Energen downgraded to Hold from Buy at Williams Capital
TER Teradyne
$41.86

0.24 (0.58%)

04/26/18
NEED
04/26/18
NO CHANGE
Target $45
NEED
Buy
Teradyne price target lowered to $45 from $52 at Needham
Needham analyst Y. Edwin Mok lowered his price target on Teradyne to $45 but kept his Buy rating, saying the company's Q1 earnings call was "more upbeat" than the "somber" Q2 guidance as the management expressed its confidence that the weakness in automatic test equipment is isolated to system-on-a-chip test only. The analyst adds that he is positive on the company's acquisition of MiR, which could reveal an even bigger market potential than its purchase of Universal Robots.
07/26/18
DADA
07/26/18
NO CHANGE
Target $45
DADA
Neutral
Teradyne price target raised to $45 from $40 at DA Davidson
DA Davidson analyst Thomas Diffely raised his price target on Teradyne to $45 after its "beat and raise" quarter, saying its Memory Test was particularly strong while the "healthy Analog and Microcontroller demand has offset the weakness in Mobility". The analyst also points to the company's strong execution, given the 400bps expansion in operating margins and memory market share gains. Diffely keeps a Neutral rating on Teradyne, given the "lack of meaningful upside" catalysts.
04/26/18
BARD
04/26/18
UPGRADE
Target $41
BARD
Outperform
Teradyne upgraded to Outperform from Neutral at Baird
Baird analyst Richard Eastman, who had downgraded Teradyne to Neutral from Outperform yesterday following the company's Q1 report, has now upgraded Teradyne back to Outperform following the stock's 16% selloff on the heels of its earnings report. He believes the pullback leaves the stock at a good entry point. Semiconductor secular trends are intact and the company has proven an ability to gain share in the test market, said Eastman, who raised his price target on Teradyne shares to $41 from $40.
05/14/18
COWN
05/14/18
INITIATION
Target $40
COWN
Market Perform
Teradyne initiated with a Market Perform at Cowen
Cowen initiated Teradyne with a Neutral and $40 price target.
NOMD Nomad Foods
$19.54

0.04 (0.21%)

06/28/18
WELS
06/28/18
INITIATION
Target $23
WELS
Outperform
Nomad Foods initiated with an Outperform at Wells Fargo
Wells Fargo analyst John Baumgartner started Nomad Foods with an Outperform rating and $23 price target, citing exposure to on-trend categories, significant opportunities for margin-accretive innovation, commitment to brand-building and marketplace investment, strong management, and M&A optionality.
11/29/17
RHCO
11/29/17
NO CHANGE
Target $20
RHCO
Buy
Nomad Foods price target raised to $20 from $17 at SunTrust
SunTrust analyst William Chappell raised his price target on Nomad Foods to $20 and kept his Buy rating after a Q3 earnings beat. Chappell says the company saw strong organic growth in the quarter, adding that it can grow further going forward. The analyst also notes that the raised outlook for this year is likely to be "highly conservative" given that performance across the company's major geographies now looks stable while the integration of Findus deal appears to be on track.
12/07/17
UBSW
12/07/17
NO CHANGE
UBSW
U.S. consumer food forecasts need to be reduced, says UBS
UBS analyst Steven Strycula noted bearish sentiment across U.S. foods has intensified since spring as volumes remain weak among increased competition. He believes Street estimates are too optimistic despite the prospects of tax reform, citing competition, limited vendor pricing amid food cost inflation, rising supply chains costs, and private label substitution risk. Strycula noted shelf space gains are slowing and any increased shelf space has not translated into volume growth. Names in the space include Pinnacle Foods (PF), Nomad Foods (NOMD) and Mondelez (MDLZ).
07/17/18
FBCO
07/17/18
INITIATION
Target $24
FBCO
Outperform
Nomad Foods initiated with an Outperform at Credit Suisse
Credit Suisse initiated Nomad Foods with an Outperform and $24 price target.
VICI VICI Properties
$20.12

0.04 (0.20%)

08/14/18
08/14/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. CREDIT SUISSE INITIATES CASINO STOCKS: Credit Suisse analyst Cameron McKnight initiated Gaming and Leisure Properties (GLPI), VICI Properties (VICI), and PlayAGS (AGS) with an Outperform, Las Vegas Sands (LVS), Wynn Resorts (WYNN), MGM Growth (MGP), and International Game (IGT) with a Neutral, as well as Scientific Games (SGMS) with an Underperform. MORGAN STANLEY RAISES SALESFORCE PRICE TARGET TO $178 FROM $153: Morgan Stanley analyst Keith Weiss raised his price target for Salesforce (CRM) shares to $178 from $153 and maintained an Overweight rating. Weiss noted that unlocking data trapped in legacy systems via MuleSoft brings the company to the forefront of driving digital transformation for its customers and added that consensus expectations likely underestimate its growth potential as well as its improved track record in M&A. JEFFRIES SAYS "SIGNIFICANT SHAREHOLDER VALUE TO BE UNLOCKED" AT NIELSEN: Even following yesterday's 12% rally, there is "significant shareholder value to be unlocked" at Nielsen Holdings (NLSN), Jefferies analyst Surinder Thind told investors in a research note. Nielsen was also upgraded to Outperform from Neutral at Macquarie and to Equal Weight from Underweight at Barclays. Morgan Stanley analyst Toni Kaplan reiterated an Overweight rating and $26 price target on the stock. NOMURA RAISES PRICE TARGET AFTER SQUARE CASH APP SURPASSED PAYPAL'S VENMO IN JULY: Nomura Instinet analyst Dan Dolev raised his price target for Square (SQ) to $86 from $82 after his firm's July payments app tracker showed cumulative Square Cash App downloads surpassed PayPal's (PYPL) Venmo for the first time. SWITCH DOWNGRADED AT MULTIPLE FIRMS: Switch (SWCH) was downgraded to Market Perform from Outperform at Raymond James, to Neutral from Overweight at JPMorgan, and to Neutral from Buy at BTIG. Switch shares are down about 25% in morning trading.
08/02/18
SBSH
08/02/18
INITIATION
Target $22
SBSH
Neutral
VICI Properties initiated with a Neutral at Citi
Citi analyst Michael Bilerman started VICI Properties with a Neutral rating and $22 price target. The analyst believes catalysts for outperformance are balanced by "identifiable risks."
08/02/18
08/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Magnolia Oil & Gas (MGY) initiated with a Buy at SunTrust. 2. VICI Properties (VICI) initiated with a Neutral at Citi. 3. Cision (CISN) initiated with a Buy at Citi. 4. Allena Pharmaceuticals (ALNA) initiated with a Buy at Ladenburg. 5. NXP Semiconductors (NXPI) reinstated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/13/18
FBCO
08/13/18
INITIATION
Target $24
FBCO
Outperform
VICI Properties initiated with an Outperform at Credit Suisse
Credit Suisse analyst Cameron McKnight started VICI Properties with an Outperform rating and $24 price target. The analyst sees "strong" growth prospects and potential upside to consensus estimates given the company's "favorable mix" of Las Vegas and regional assets.
HES Hess Corp.
$63.92

0.6 (0.95%)

07/18/18
MUFG
07/18/18
NO CHANGE
Target $78
MUFG
Overweight
Hess Corp price target raised to $78 from $61 at MUFG
MUFG analyst Michael McAllister raised his price target on Hess Corp. to $78 and kept his Overweight rating, saying the higher oil price has contributed to the 46% rise in its stock price over the past 12 months, but investors are also increasingly focused on the 2020 start of production in Guyana. McAllister adds that his recent price deck update "improves this oil-linked company's outlook, estimating a 20% increase in revenue per barrel of oil equivalent to ~$44.50 for 2018 versus 2017." The analyst also cites the production growth outlook driven by Williston Basin and Guyana barrels and only a slight valuation premium for Hess at 8.0-times enterprise value to expected two-year forward EBITDAX vs. 7.5-times peer group average.
07/23/18
MZHO
07/23/18
INITIATION
Target $80
MZHO
Neutral
Hess Corp. initiated with a Neutral at Mizuho
Mizuho analyst Paul Sankey started Hess Corp. with a Neutral rating and $80 price target.
07/12/18
MSCO
07/12/18
INITIATION
Target $84
MSCO
Overweight
Hess Corp. initiated with an Overweight at Morgan Stanley
Morgan Stanley analysts Devin McDermott and Drew Venker added coverage of 12 large-cap and diversified E&Ps, including Hess Corp., which they started with an $84 price target and Overweight rating.
DISH Dish
$35.63

0.63 (1.80%)

08/13/18
MOFT
08/13/18
DOWNGRADE
MOFT
Sell
Dish downgraded to Sell from Neutral at MoffettNathanson
08/13/18
08/13/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Rite Aid (RAD) downgraded to Market Perform from Outperform at Cowen with analyst Charles Rhyee saying shares of Ride Aid adequately reflect its outlook, following the termination of the company's merger with Albertsons. 2. Akamai (AKAM) downgraded to Neutral from Outperform at Credit Suisse with analyst Brad Zelnick saying with the stock up 29% since Elliott Management's disclosure of a stake on December 15, 2017, many of the catalysts have played out. 3. Alnylam (ALNY) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Terence Flynn saying the lack of cardio data in the approved U.S. label for Onpattro is disappointing and could represent a disadvantage versus Pfizer's (PFE) competitor drug Tafamadis. 4. Goodyear Tire (GT) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Armintas Sinkevicius saying he remains "constructive" on the long-term growth for global miles traveled, but believes this will not affect the stock for the next 12 months due to the overhang from estimate achievability. 5. Dish (DISH) downgraded to Sell from Neutral at MoffettNathanson with analyst Craig Moffett saying while the reported Q2 business conditions in the core satellite TV business were "genuinely better" amid reduced churn and slower subscriber losses, the Spectrum segment -- which holds "all" of the company's equity value -- is worse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/13/18
08/13/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GOLDMAN SACHS CUTS ALNYLAM TO BUY: Goldman Sachs analyst Terence Flynn downgraded Alnylam (ALNY) to Buy from Conviction Buy. The analyst also lowered his price target for the shares to $155 from $193. Flynn said the lack of cardio data in the approved U.S. label for Onpattro is disappointing and could represent a disadvantage versus Pfizer's (PFE) competitor drug Tafamadis. Piper Jaffray analyst Edward Tenthoff recommended buying shares of Alnylam Pharmaceuticals on weakness following the approval of Onpattro. Morgan Stanley analyst David Lebowitz lowered his price target to $93, Nomura Instinet analyst Christopher Marai lowered his price target to $73, and Stifel analyst Paul Matteis maintained a Buy rating but cut his price target to $123 from $125 and slightly lowered his revenue ramp for the drug based on modestly reduced share in mixed-phenotype haTTR patients and lower share in cardiac-only haTTR patients. B. Riley FBR analyst Madhu Kumar raised his price target to $230. RUBIUS THERAPEUTICS INITIATED AT MULTIPLE FIRMS: Rubius Therapeutics (RUBY) was initiated with an Outperform at Leerink, an Overweight at JPMorgan and Morgan Stanley, as well as a Buy at Jefferies. PIPER JAFFRAY SAYS AMAZON AD BUSINESS GROWING INTO PROFIT DRIVER: Amazon's (AMZN) advertising business "has been quietly growing into a massive driver of current and future profitability," Piper Jaffray analyst Michael Olson told investors in a research note. Applying an advertising comp multiple of 16 times to estimated 2020 Amazon advertising operating income suggests an ad business that should be valued at $150B-$190B, Olson contended. IMPERIAL CAPITAL CUTS NETFLIX PRICE TARGET TO $494: Imperial Capital analyst David Miller lowered his price target for Netflix (NFLX) to $494 after he slightly reduced his global subscriber estimates. The analyst said that in the "interest of being conservative," he decreased his fiscal 2018 global subscriber estimate to 141.2M from 141.4M and fiscal 2019 global subscriber estimate to 164.4M from 166.3M. DISH DOWNGRADED TO SELL AT MOFFETTNATHANSON: MoffettNathanson analyst Craig Moffett downgraded Dish (DISH) to Sell from Neutral with a price target of $29 and noted that while the reported Q2 business conditions in the core satellite TV business were "genuinely better" amid reduced churn and slower subscriber losses, the Spectrum segment -- which holds "all" of the company's equity value -- is worse.
08/13/18
MOFT
08/13/18
DOWNGRADE
Target $29
MOFT
Sell
Dish downgraded to Sell at MoffettNathanson on deteriorating spectrum
As reported earlier, MoffettNathanson analyst Craig Moffett downgraded Dish to Sell from Neutral with a price target of $29. The analyst notes that while the reported Q2 business conditions in the core satellite TV business were "genuinely better" amid reduced churn and slower subscriber losses, the Spectrum segment - which holds "all" of the company's equity value - is worse. Moffett states that all considerations for the business aside from Spectrum sale, including the network buildout, is a negative for Dish, adding that the Q2 report has only made the "other scenarios more likely".
EQT EQT Corporation
$50.34

0.98 (1.99%)

08/06/18
MSCO
08/06/18
NO CHANGE
Target $59
MSCO
Equal Weight
Mountain Vally stop order ups risk for more delays for EQT, says Morgan Stanley
After the Federal Energy Regulatory Commission issued a project-wide stop work order for the Mountain Valley Pipeline project, which is partially owned by EQT Midstream Partners (EQM), Morgan Stanley analyst Drew Venker said this shouldn't be a big surprise given key permits had been vacated, but he also believes it does increase the risk of further project delays. Venker, who continues to expect in service in full for the Mountain Valley Pipeline is most likely between Q2 and Q3 of 2019, keeps an Equal Weight rating and $59 price target on EQT Corporation (EQT) shares.
07/05/18
TDSI
07/05/18
INITIATION
Target $57
TDSI
Hold
EQT Corporation initiated with a Hold at TD Securities
TD Securities analyst Menno Hulshof initiated EQT Corporation with a Hold and $57 price target.
06/13/18
JPMS
06/13/18
NO CHANGE
Target $70
JPMS
Overweight
EQT midstream separation a catalyst for shares, says JPMorgan
JPMorgan analyst Arun Jayaram believes the separation of EQT Corporation's exploration and production and midstream segments is on track for completion during Q2, which should be a "catalyst to narrow the sum-of-the parts discount." After "re-running a lot of math," the analyst continues to see a "compelling idiosyncratic trading opportunity" in the stock given the discounted valuation, balance sheet strength, and attractive combination of growth and free cash flow generation. He keeps an Overweight rating on EQT with a $70 price target.
07/05/18
07/05/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Deciphera (DCPH) initiated with a Buy at SunTrust. 2. EQT Corporation (EQT) initiated with a Hold at TD Securities. 3. Pioneer Natural (PXD) initiated with a Buy at TD Securities. 4. Veoneer (VNE) initiated with an Overweight at Barclays. 5. Valeritas (VLRX) initiated with an Outperform at Oppenheimer. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
MFGP Micro Focus
$15.79

-0.325 (-2.02%)

07/16/18
FBCO
07/16/18
DOWNGRADE
FBCO
Underperform
Micro Focus downgraded to Underperform from Neutral at Credit Suisse
Credit Suisse analyst Charles Brennan downgraded Micro Focus International to Neutral and lowered his price target for the shares to GBP 11.02 from GBP 12. The analyst sees a "difficult" path for shares following the company's interim results. He believes management did not provide a roadmap to revenue stability.
01/10/18
UBSW
01/10/18
UPGRADE
UBSW
Buy
Micro Focus upgraded to Buy from Neutral at UBS
05/17/18
ADAM
05/17/18
UPGRADE
ADAM
Buy
Micro Focus upgraded to Buy from Speculative Buy at Canaccord
QQQ Invesco QQQ Trust
$181.44

1.1 (0.61%)

CDK CDK Global
$61.75

-2.08 (-3.26%)

05/29/18
BRRR
05/29/18
UPGRADE
Target $80
BRRR
Outperform
CDK Global upgraded to Outperform with $80 target at Barrington
Barrington analyst Gary Prestopino upgraded CDK Global to Outperform from Market Perform with an $80 price target. CDK is shifting its investment theme to consistent growth and margin expansion within its highly leverageable network of dealers through market share gains, layered application sales and strategic acquisitions, Prestopino tells investors in a research note after spending time with management. CDK's priorities will be focused on revenue and adjusted EBITDA growth, the analyst adds. He views the stock's valuation as compelling at current levels.
05/29/18
BRRR
05/29/18
UPGRADE
BRRR
Outperform
CDK Global upgraded to Outperform from Market Perform at Barrington
01/17/18
BRRR
01/17/18
DOWNGRADE
Target $75
BRRR
Market Perform
CDK Global downgraded to Market Perform on valuation at Barrington
Barrington analyst Gary Prestopino downgraded CDK Global to Market Perform from Outperform citing valuation following the stock's recent rally. A financial buyer may not pay much more of a premium for the company, Prestopino tells investors in a research note, referencing media reports indicating CDK is exploring a sale. The analyst keeps a $75 price target for the shares.
01/31/18
WELS
01/31/18
NO CHANGE
Target $80
WELS
Outperform
CDK Global price target raised to $80 from $75 at Wells Fargo
Wells Fargo analyst Timothy Willi raised his price target for CDK Global to $80 from $75 following quarterly results. The analyst reiterates an Outperform rating on the shares.
ISBC Investors Bancorp
$12.77

0.17 (1.35%)

05/04/18
LEHM
05/04/18
UPGRADE
Target $15
LEHM
Equal Weight
Investors Bancorp upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Matthew Keating upgraded Investors Bancorp to Equal Weight and raised his price target for the shares to $15 from $14. The analyst believes the company will meet or modestly exceed consensus earnings estimates for 2018 and 2019. Further, he believes board changes could lead to Investors Bancorp considering additional strategic actions.
04/05/18
SDLR
04/05/18
UPGRADE
Target $15.5
SDLR
Buy
Sandler upgrades Investors Bancorp to Buy after management meetings
Sandler O'Neill analyst Mark Fitzgibbon upgraded Investors Bancorp to Buy from Hold with a price target of $15.50. The analyst left recent meetings with management "incrementally more bullish" on the company's outlook. Following the 7% pullback in the shares since his downgrade to Hold in November, Fitzgibbon upgrades Investors Bancorp back to Buy.
11/30/17
SDLR
11/30/17
DOWNGRADE
Target $15.5
SDLR
Hold
Investors Bancorp downgraded to Hold on valuation at Sandler O'Neill
Sandler O'Neill analyst Mark Fitzgibbon downgraded Investors Bancorp to Hold from Buy citing valuation with the shares up 3% over the past three trading days. The analyst keeps a $15.50 price target for the shares.
04/05/18
SDLR
04/05/18
UPGRADE
SDLR
Buy
Investors Bancorp upgraded to Buy from Hold at Sandler O'Neill
WIT Wipro
$5.12

(0.00%)

06/26/18
NOMU
06/26/18
UPGRADE
NOMU
Neutral
Wipro upgraded to Neutral from Reduce at Nomura Instinet
07/05/18
HSBC
07/05/18
UPGRADE
HSBC
Hold
Wipro upgraded to Hold from Reduce at HSBC
07/05/18
LYON
07/05/18
UPGRADE
LYON
Underperform
Wipro upgraded to Underperform from Sell at CLSA
07/24/18
LYON
07/24/18
DOWNGRADE
LYON
Sell
Wipro downgraded to Sell from Underperform at CLSA
IMPV Imperva
$45.55

-0.85 (-1.83%)

07/27/18
DADA
07/27/18
DOWNGRADE
DADA
Neutral
Imperva downgraded to Neutral from Buy at DA Davidson
07/27/18
MONN
07/27/18
DOWNGRADE
MONN
Neutral
Imperva downgraded to Neutral from Buy at Monness Crespi
07/27/18
OPCO
07/27/18
DOWNGRADE
OPCO
Perform
Imperva downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Shaul Eyal downgraded Imperva to Perform from Outperform after the company reported "disappointing" Q2 results. In a research note to investors, Eyal says he is moving to the sidelines, as Imperva needs more time to complete its model transition and U.S. restructuring initiatives. The analyst says that while yesterday's after-hours shares' move could be perceived as an attractive valuation level, he would stay away for now.
07/27/18
DADA
07/27/18
DOWNGRADE
Target $46
DADA
Neutral
Imperva downgraded to Neutral at DA Davidson on subscription revenue transition
As reported earlier, DA Davidson analyst Mark Kelleher downgraded Imperva to Neutral from Buy and lowered his price target to $46 from $56. The analyst notes that while the company's focus on the security market and the DDoS opportunity is a positive, the faster than anticipated transition to subscription revenue model is weighing on top-line growth. Kelleher adds that earnings are also constrained by Imperva's acquisition costs, forecasting 2019 as a transition year when the company can work to improve its salesforce productivity.
NXPI NXP Semiconductors
$91.21

-1.92 (-2.06%)

07/30/18
NEED
07/30/18
NO CHANGE
Target $120
NEED
Strong Buy
NXP Semiconductors price target lowered to $120 from $130 at Needham
Needham analyst Rajvindra Gill lowered his price target on NXP Semiconductors (NXPI) to $120 to reflect last week's sell-off that followed its earnings, buyback, and terminated Qualcomm (QCOM) deal. The analyst also keeps his Strong Buy rating and believes that investors will re-evaluated the shares, given that the company's revenue mix is much healthier on combination of auto, industrial and internet of things end markets, while the revenues lost from ZTE (ZTCOY) component import ban should resume in Q3.
08/02/18
LEHM
08/02/18
INITIATION
Target $100
LEHM
Equal Weight
NXP Semiconductors reinstated with an Equal Weight at Barclays
Barclays analyst Blayne Curtis reinstated coverage of NXP Semiconductors with an Equal Weight rating and $100 price target. The analyst sees "too much uncertainty on the top and bottom line" for a more constructive rating at this time. He believes NXP shares will trade at a discount to "higher quality" analog peers.
08/14/18
MZHO
08/14/18
NO CHANGE
MZHO
Buy
ON Semiconductor pullback a buying opportunity, says Mizuho
Mizuho analyst Vijay Rakesh views the recent pullback in shares of ON Semiconductor (ON) as a buying opportunity. The analyst attributes the selloff to concerns of a peaking semi cycle, but points out that over the last four-years, ON's exposure to auto and industrial revenue has almost doubled. However, the stock trades at a 50% discount to automotive and industrial peers including Texas Instruments (TXN), NXP Semiconductors (NXPI), Analog Devices (ADI), Maxim Integrated (MXIM) and Monolithic Power (MPWR), Rakesh tells investors in a research note.
BTU Peabody Energy
$42.39

-0.12 (-0.28%)

04/02/18
RILY
04/02/18
NO CHANGE
Target $51
RILY
Buy
Peabody Energy capital return story underappreciated, says B. Riley FBR
B. Riley FBR analyst Lucas Pipes believes Peabody Energy's capital return story remains underappreciated at current share levels. The analyst boosted his price target for the stock to $51 from $50 and keeps a Buy rating on the name.
01/25/18
JPMS
01/25/18
DOWNGRADE
Target $90
JPMS
Neutral
JPMorgan downgrades Arch after rally, ups target on Peabody
JPMorgan analyst John Bridges downgraded Arch Coal (ARCH) to Neutral from Overweight with an unchanged price target of $90. The analyst finds the shares "reasonably valued" following the 30% rally over the past three months. He recommends taking profits at current levels. Bridges also raised his price target for Overweight-rated Peabody Energy (BTU) to $52 from $37. The analyst notes his new price target reflects 30% upside from current levels.
06/06/18
MKMP
06/06/18
NO CHANGE
Target $106
MKMP
Buy
MKM Partners reiterates Buy ratings on Arch Coal, Peabody, Teck Resources
MKM Partners analyst Daniel Scott reiterated Buy ratings on Arch Coal (ARCH), Peabody Energy (BTU) and Teck Resources (TECK), telling investors in a research note that after a prolonged down cycle in coking coal prices, the strength seen for almost two years suggests that supply/demand fundamentals remain "favorable" for producers. The analyst notes that while the fundamentals for domestic thermal coal are improving slowly, exposure to export coking coal is his preferred story. Scott has a $106 price target on Arch Coal, a $53 price target on Peabody and $35 price target on Teck Resources.
12/05/17
JEFF
12/05/17
NO CHANGE
Target $43
JEFF
Buy
Peabody Energy price target raised to $43 from $38 at Jefferies
Jefferies analyst Christopher LaFemina believes "large scale" capital returns should help drive Peabody Energy shares higher even if seaborne coal prices move lower. The analyst expects the company to complete its current $500M buyback and initiate an ordinary dividend in Q1 of 2018. He views the shares as undervalued and keeps a Buy rating on Peabody.
ARNC Arconic
$20.69

0.29 (1.42%)

07/16/18
FBCO
07/16/18
NO CHANGE
Target $28
FBCO
Outperform
Arconic could be worth $24-$26 per share in buyout, says Credit Suisse
Credit Suisse analyst Curt Woodworth views Arconic (ARNC) as a "very viable" leveraged buyout candidate given its "highly depressed" multiples, operational and financial mismanagement, and "very strong" positions in automotive and aerospace end markets. The analyst believes the company could be worth $24-$26 per share in a buyout. The stock in morning trading is up 9%, or $1.60, to $18.98 after the Wall Street Journal reported that Arconic is the subject of takeover interest from private equity firms including Apollo Global Management (APO). Woodworth has an Outperform rating on the shares with a $28 price target.
05/31/18
ARGS
05/31/18
DOWNGRADE
ARGS
Hold
Arconic downgraded to Hold from Buy at Argus
Argus analyst John Eade downgraded Arconic to Hold from Buy, telling investors in a research note that shares have underperformed the market over the past quarter and its share price has been volatile over the last year, rising on expectations for infrastructure spending under the Trump administration and then falling on concerns about the role of its products in the fatal Grenfell Tower fire. The analyst says he may look to get Arconic shares back to a Buy rating once margins show signs of stabilizing.
07/16/18
JEFF
07/16/18
INITIATION
Target $23
JEFF
Buy
Arconic initiated with a Buy at Jefferies
Jefferies analyst Martin Englert started Arconic with a Buy rating and $23 price target. The company's "depressed" share price "creates a window of optionality" for management to utilize its $500M buyback and the recent reported interest from private equity is likely supportive of the valuation, Englert tells investors in a research note.
07/16/18
MSCO
07/16/18
NO CHANGE
Target $20
MSCO
Equal Weight
Morgan Stanley says Arconic LBO could work, but execution matters in near-term
After The Wall Street Journal reported that Arconic has received "expressions of interest" from a number of private-equity firms, Morgan Stanley analyst Rajeev Lalwani said two things stand out to make Arconic a plausible LBO candidate: its low EV/EBITDA multiple and its a cash flow profile, which has room for improvement. While the reported private equity interest "adds a level of intrigue," Lalwani still believes headwinds within it rings and disks business, working capital and capex issues and volatility associated with aluminum prices will be the key driver of shares in the near-term. Given the aforementioned execution concerns, Lalwani keeps an Equal Weight rating and $20 price target on Arconic shares, which are up 12% to $19.53 in pre-market trading.

TODAY'S FREE FLY STORIES

TROX

Tronox

$7.05

-0.25 (-3.42%)

18:46
12/10/18
12/10
18:46
12/10/18
18:46
Hot Stocks
Tronox CEO discloses purchase of 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGT

Allegiant Travel

$124.89

-1.45 (-1.15%)

18:37
12/10/18
12/10
18:37
12/10/18
18:37
Hot Stocks
Allegiant reports November total systems traffic up 10.1% »

Reports total systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$108.55

2.85 (2.70%)

18:27
12/10/18
12/10
18:27
12/10/18
18:27
Periodicals
Splunk CEO says customers can now talk via voice-enabled assistants, CNBC says »

Splunk president and CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 19

    Dec

  • 20

    Dec

  • 09

    Jan

EFC

Ellington Financial

$15.57

0.01 (0.06%)

18:22
12/10/18
12/10
18:22
12/10/18
18:22
Hot Stocks
Ellington Financial reports book value per share of $19.37 as of Nov. 30th »

Ellington Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

18:22
12/10/18
12/10
18:22
12/10/18
18:22
Periodicals
New 'Smash Bros.' fastest selling Switch game so far, Gamesindustry.biz says »

Nintendo's latest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,040.02

3.5 (0.34%)

, GOOGL

Alphabet Class A

$1,052.80

5.81 (0.55%)

18:15
12/10/18
12/10
18:15
12/10/18
18:15
Periodicals
Google CEO supports privacy law, denies political bias, Bloomberg says »

Google CEO Sundar Pichai…

GOOG

Alphabet

$1,040.02

3.5 (0.34%)

GOOGL

Alphabet Class A

$1,052.80

5.81 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 03

    Mar

APTI

Apptio

$37.86

-0.17 (-0.45%)

18:13
12/10/18
12/10
18:13
12/10/18
18:13
Downgrade
Apptio rating change  »

Apptio downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NMRK

Newmark

$8.56

0.21 (2.52%)

18:00
12/10/18
12/10
18:00
12/10/18
18:00
Hot Stocks
Newmark CEO Barry Gosin buys over $2.6M in company shares »

Newmark CEO Barry Gosin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVTC

Evertec

$26.83

-0.365 (-1.34%)

17:52
12/10/18
12/10
17:52
12/10/18
17:52
Hot Stocks
Evertec EVP Ramirez sells 44,378 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 18

    Dec

ALTM

Altus Midstream Company

$8.50

0.6 (7.59%)

, APA

Apache

$31.27

-1.74 (-5.27%)

17:46
12/10/18
12/10
17:46
12/10/18
17:46
Hot Stocks
Apache reports 13.4% stake in Altus Midstream Company »

This stake allows for…

ALTM

Altus Midstream Company

$8.50

0.6 (7.59%)

APA

Apache

$31.27

-1.74 (-5.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHT

Red Hat

$177.13

0.03 (0.02%)

, IBM

IBM

$121.13

1.77 (1.48%)

17:45
12/10/18
12/10
17:45
12/10/18
17:45
Hot Stocks
Red Hat sets January 16 special meeting for vote on IBM merger »

Red Hat, Inc. (RHT)…

RHT

Red Hat

$177.13

0.03 (0.02%)

IBM

IBM

$121.13

1.77 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

YMAB

Y-mAbs Therapeutics

$22.17

-0.36 (-1.60%)

17:42
12/10/18
12/10
17:42
12/10/18
17:42
Hot Stocks
Y-mAbs Therapeutics humanized bispecific GD2 antibody IND receives FDA clearance »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Shares

$117.68

-0.39 (-0.33%)

17:39
12/10/18
12/10
17:39
12/10/18
17:39
Hot Stocks
SPDR Gold Shares holdings rise to 760.32MT from 759.73MT »

This is the second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAEX

SAExploration

$3.33

-0.11 (-3.20%)

17:35
12/10/18
12/10
17:35
12/10/18
17:35
Syndicate
SAExploration files to sell common stock for holders »

SAExploration filed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$40.47

-0.25 (-0.61%)

17:27
12/10/18
12/10
17:27
12/10/18
17:27
Syndicate
Breaking Syndicate news story on Biohaven Pharmaceutical »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WCC

Wesco

$49.28

-0.675 (-1.35%)

17:26
12/10/18
12/10
17:26
12/10/18
17:26
Initiation
Wesco initiated  »

Wesco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

MTEM

Molecular Templates

$4.30

-0.08 (-1.83%)

17:25
12/10/18
12/10
17:25
12/10/18
17:25
Initiation
Molecular Templates initiated  »

Molecular Templates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

COHR

Coherent

$119.34

-0.28 (-0.23%)

17:23
12/10/18
12/10
17:23
12/10/18
17:23
Initiation
Coherent initiated  »

Coherent initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAMP

CalAmp

$17.02

-0.23 (-1.33%)

17:22
12/10/18
12/10
17:22
12/10/18
17:22
Hot Stocks
CalAmp announces $20M stock repurchase program »

CalAmp announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CR

Crane

$78.23

-0.99 (-1.25%)

17:22
12/10/18
12/10
17:22
12/10/18
17:22
Initiation
Crane initiated  »

Crane initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTX

BioTime

$1.31

-0.03 (-2.24%)

17:22
12/10/18
12/10
17:22
12/10/18
17:22
Initiation
BioTime initiated  »

BioTime initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVAX

Novavax

$2.14

0.09 (4.39%)

17:20
12/10/18
12/10
17:20
12/10/18
17:20
Initiation
Novavax initiated  »

Novavax initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$207.84

-3.275 (-1.55%)

17:19
12/10/18
12/10
17:19
12/10/18
17:19
Initiation
Lennox initiated  »

Lennox initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

FCAU

Fiat Chrysler

$15.33

(0.00%)

17:17
12/10/18
12/10
17:17
12/10/18
17:17
Hot Stocks
Breaking Hot Stocks news story on Fiat Chrysler »

Tiger Global reports 5.1%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$169.61

1.24 (0.74%)

17:15
12/10/18
12/10
17:15
12/10/18
17:15
Recommendations
Apple analyst commentary  »

Apple pullback is a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.